89 related articles for article (PubMed ID: 10949846)
1. [Antibiotic sensitivity of enterobacteria in intensive care units].
Pina P; Pangon B; Rio Y; Chardon H; Lallali AK; Allouch PY
Pathol Biol (Paris); 2000 Jun; 48(5):485-9. PubMed ID: 10949846
[TBL] [Abstract][Full Text] [Related]
2. Relationship between the distribution of cefepime minimum inhibitory concentrations and detection of extended-spectrum β-lactamase production among clinically important Enterobacteriaceae isolates obtained from patients in intensive care units in Taiwan: results from the Surveillance of Multicenter Antimicrobial Resistance in Taiwan (SMART) in 2007.
Jean SS; Lee WS; Bai KJ; Lam C; Hsu CW; Yu KW; Liao CH; Chang FY; Ko WC; Wu JJ; Chen YH; Chen YS; Liu JW; Lu MC; Liu CY; Chen RJ; Hsueh PR
J Microbiol Immunol Infect; 2015 Feb; 48(1):85-91. PubMed ID: 23973410
[TBL] [Abstract][Full Text] [Related]
3. [Sensitivity to antibiotics of bacteria from nosocomial infections. Evolution in resuscitation services of military hospitals].
Garrabé E; Cavallo JD; Brisou P; Chapalain JC; Coué JC; Courrier P; Granic G; Hervé V; Koeck JL; Morillon M; Claude JD; Rouby Y; Teyssou R
Presse Med; 2000 Sep; 29(27):1497-503. PubMed ID: 11045115
[TBL] [Abstract][Full Text] [Related]
4. [Continuous surveillance of antimicrobial resistance among nosocomial gram-negative bacilli from intensive care units in China].
Chen MJ; Wang H;
Zhonghua Yi Xue Za Zhi; 2003 Mar; 83(5):375-81. PubMed ID: 12820912
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of MicroScan WalkAway and Vitek 2 for determination of the susceptibility of extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella pneumoniae isolates to cefepime, cefotaxime and ceftazidime.
Jang W; Park YJ; Park KG; Yu J
J Antimicrob Chemother; 2013 Oct; 68(10):2282-5. PubMed ID: 23671215
[TBL] [Abstract][Full Text] [Related]
6. Activity of ertapenem and other antimicrobials against ESBL-producing enterobacteria isolated from urine in patients from Madrid.
Tamayo J; Orden B; Cacho J; Cuadros J; Gomez-Garces JL; Alos JI
Rev Esp Quimioter; 2007 Sep; 20(3):334-8. PubMed ID: 18080031
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of a new cefepime-clavulanate ESBL Etest to detect extended-spectrum beta-lactamases in an Enterobacteriaceae strain collection.
Stürenburg E; Sobottka I; Noor D; Laufs R; Mack D
J Antimicrob Chemother; 2004 Jul; 54(1):134-8. PubMed ID: 15150168
[TBL] [Abstract][Full Text] [Related]
8. In vitro susceptibilities of clinical isolates of ertapenem-non-susceptible Enterobacteriaceae to cefotaxime, ceftazidime, cefepime and aztreonam.
Cheng NC; Liu CY; Huang YT; Liao CH; Teng LJ; Hsueh PR
J Antimicrob Chemother; 2012 Jun; 67(6):1413-21. PubMed ID: 22345386
[TBL] [Abstract][Full Text] [Related]
9. [Occurrence of alert pathogens in hospital environment. Part I. ESBL-producing enterobacteriaceae strains].
Paluchowska P; Skałkowska M; Spelak A; Budak A
Med Dosw Mikrobiol; 2012; 64(1):35-43. PubMed ID: 22808728
[TBL] [Abstract][Full Text] [Related]
10. Extended-spectrum beta-lactamase producing strains of Enterobacter cloacae transferring resistance to cefotaxime and ceftazidime.
Blahová J; Králiková K; Krcméry V; Schäfer V
J Chemother; 1999 Apr; 11(2):97-102. PubMed ID: 10326739
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of a new selective chromogenic agar medium for detection of extended-spectrum beta-lactamase-producing Enterobacteriaceae.
Glupczynski Y; Berhin C; Bauraing C; Bogaerts P
J Clin Microbiol; 2007 Feb; 45(2):501-5. PubMed ID: 17182756
[TBL] [Abstract][Full Text] [Related]
12. [Comparison of the results of the Etest and the method for determining minimum inhibitory concentrations in solid media for penicillin G, amoxicillin, and cefotaxime for S. pneumoniae. A multicenter study].
Clavier B; Perrier-Gros-Claude JD; Foissaud V; Dumas M; Aubert G; Barbé G; Bland S; Boucaud Maitre Y; Boyer M; Chomarat M; Clergeau P; Delubac F; Févre D; Fuhrmann C; Gravagnat B; Letouzey MN; Mandjee A; Martelet P; Meley R; Reverdy ME; Ros A; Roure C; Sabot O; Tixier A; Thierry J
Pathol Biol (Paris); 1998 Jun; 46(6):369-74. PubMed ID: 9769863
[TBL] [Abstract][Full Text] [Related]
13. [Effect of ceftazidime on enterobacteria and Pseudomonas producers of beta-lactamases].
Chabbert YA; Derlot E; Courvalin P
Pathol Biol (Paris); 1985 Sep; 33(7):758-63. PubMed ID: 3936006
[TBL] [Abstract][Full Text] [Related]
14. In vitro activity of newer broad spectrum beta-lactam antibiotics against enterobacteriaceae and non-fermenters: a report from Austrian intensive care units. Austrian Carbapenem Susceptibility Surveillance Group.
Krause R; Mittermayer H; Feierl G; Allerberger F; Wendelin I; Hirschl A; Reisinger EC
Wien Klin Wochenschr; 1999 Jul; 111(14):549-54. PubMed ID: 10467641
[TBL] [Abstract][Full Text] [Related]
15. Sensitivity of Enterobacteriaceae strains to the third generation cephalosporins.
Poiată A; Filip R; Tuchiluş C; Constantiniu S; Dumistracel I; Popa C; Lăcătuş C; Buiuc D
Rev Med Chir Soc Med Nat Iasi; 2000; 104(2):131-4. PubMed ID: 12089977
[TBL] [Abstract][Full Text] [Related]
16. The use of antibiotic-containing agars for the isolation of extended-spectrum beta-lactamase-producing organisms in intensive care units.
Wilson G; McCabe D
Clin Microbiol Infect; 2007 Apr; 13(4):451-3. PubMed ID: 17359334
[TBL] [Abstract][Full Text] [Related]
17. [In-vitro activity of ceftriaxone on Gram-negative bacilli with various resistance phenotypes to cephalosporins. Comparison with cefotaxime, cefmenoxime, moxalactam, ceftazidime].
Rouhan D; Le Noc P; Le Noc D
Pathol Biol (Paris); 1986 May; 34(5):404-9. PubMed ID: 3534713
[TBL] [Abstract][Full Text] [Related]
18. In vitro antibacterial activity of ceftobiprole against clinical isolates from French teaching hospitals: proposition of zone diameter breakpoints.
Lascols C; Legrand P; Mérens A; Leclercq R; Muller-Serieys C; Drugeon HB; Kitzis MD; Reverdy ME; Roussel-Delvallez M; Moubareck C; Brémont S; Miara A; Gjoklaj M; Soussy CJ
Int J Antimicrob Agents; 2011 Mar; 37(3):235-9. PubMed ID: 21295447
[TBL] [Abstract][Full Text] [Related]
19. [Development of Beta-lactamase resistance in enterobacteria].
Koren J; Vaculíková A
Klin Mikrobiol Infekc Lek; 2006 Jun; 12(3):103-7. PubMed ID: 17051471
[TBL] [Abstract][Full Text] [Related]
20. [Prevalence of extended-spectrum beta-lactamases in nosocomial Escherichia coli and Klebsiella spp. strains isolated from blood cultures].
Zarakolu P; Metan G; Hasçelik G; Akova M
Mikrobiyol Bul; 2007 Oct; 41(4):579-84. PubMed ID: 18173077
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
